Global IBS-C Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global IBS-C Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the IBS-C Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global IBS-C Drug market. IBS-C Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of IBS-C Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the IBS-C Drug market.
IBS?C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS?C are defined as long-lasting and keep coming back. Those suffering from IBS?C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on IBS-C Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the IBS-C Drug market. It may include historical data, market segmentation by Type (e.g., Amitiza, Lactulose), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the IBS-C Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the IBS-C Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the IBS-C Drug industry. This include advancements in IBS-C Drug technology, IBS-C Drug new entrants, IBS-C Drug new investment, and other innovations that are shaping the future of IBS-C Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the IBS-C Drug market. It includes factors influencing customer ' purchasing decisions, preferences for IBS-C Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the IBS-C Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting IBS-C Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the IBS-C Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the IBS-C Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the IBS-C Drug market.
Market Segmentation:
IBS-C Drug market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global IBS-C Drug market?
What factors are driving IBS-C Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IBS-C Drug market opportunities vary by end market size?
How does IBS-C Drug break out type, distribution channel?
According to our LPI (LP Information) latest study, the global IBS-C Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the IBS-C Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global IBS-C Drug market. IBS-C Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of IBS-C Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the IBS-C Drug market.
IBS?C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS?C are defined as long-lasting and keep coming back. Those suffering from IBS?C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on IBS-C Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the IBS-C Drug market. It may include historical data, market segmentation by Type (e.g., Amitiza, Lactulose), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the IBS-C Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the IBS-C Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the IBS-C Drug industry. This include advancements in IBS-C Drug technology, IBS-C Drug new entrants, IBS-C Drug new investment, and other innovations that are shaping the future of IBS-C Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the IBS-C Drug market. It includes factors influencing customer ' purchasing decisions, preferences for IBS-C Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the IBS-C Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting IBS-C Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the IBS-C Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the IBS-C Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the IBS-C Drug market.
Market Segmentation:
IBS-C Drug market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value.
Segmentation by type
- Amitiza
- Lactulose
- Milk of Magnesia
- LINZESS (Linaclotide)
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan
- Takeda
- Sucampo Pharmaceuticals
- IM HealthScience
What is the 10-year outlook for the global IBS-C Drug market?
What factors are driving IBS-C Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IBS-C Drug market opportunities vary by end market size?
How does IBS-C Drug break out type, distribution channel?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IBS-C Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for IBS-C Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for IBS-C Drug by Country/Region, 2019, 2023 & 2030
2.2 IBS-C Drug Segment by Type
2.2.1 Amitiza
2.2.2 Lactulose
2.2.3 Milk of Magnesia
2.2.4 LINZESS (Linaclotide)
2.2.5 Others
2.3 IBS-C Drug Sales by Type
2.3.1 Global IBS-C Drug Sales Market Share by Type (2019-2024)
2.3.2 Global IBS-C Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global IBS-C Drug Sale Price by Type (2019-2024)
2.4 IBS-C Drug Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 IBS-C Drug Sales by Distribution Channel
2.5.1 Global IBS-C Drug Sale Market Share by Distribution Channel (2019-2024)
2.5.2 Global IBS-C Drug Revenue and Market Share by Distribution Channel (2019-2024)
2.5.3 Global IBS-C Drug Sale Price by Distribution Channel (2019-2024)
3 GLOBAL IBS-C DRUG BY COMPANY
3.1 Global IBS-C Drug Breakdown Data by Company
3.1.1 Global IBS-C Drug Annual Sales by Company (2019-2024)
3.1.2 Global IBS-C Drug Sales Market Share by Company (2019-2024)
3.2 Global IBS-C Drug Annual Revenue by Company (2019-2024)
3.2.1 Global IBS-C Drug Revenue by Company (2019-2024)
3.2.2 Global IBS-C Drug Revenue Market Share by Company (2019-2024)
3.3 Global IBS-C Drug Sale Price by Company
3.4 Key Manufacturers IBS-C Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IBS-C Drug Product Location Distribution
3.4.2 Players IBS-C Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IBS-C DRUG BY GEOGRAPHIC REGION
4.1 World Historic IBS-C Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global IBS-C Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global IBS-C Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic IBS-C Drug Market Size by Country/Region (2019-2024)
4.2.1 Global IBS-C Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global IBS-C Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas IBS-C Drug Sales Growth
4.4 APAC IBS-C Drug Sales Growth
4.5 Europe IBS-C Drug Sales Growth
4.6 Middle East & Africa IBS-C Drug Sales Growth
5 AMERICAS
5.1 Americas IBS-C Drug Sales by Country
5.1.1 Americas IBS-C Drug Sales by Country (2019-2024)
5.1.2 Americas IBS-C Drug Revenue by Country (2019-2024)
5.2 Americas IBS-C Drug Sales by Type
5.3 Americas IBS-C Drug Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IBS-C Drug Sales by Region
6.1.1 APAC IBS-C Drug Sales by Region (2019-2024)
6.1.2 APAC IBS-C Drug Revenue by Region (2019-2024)
6.2 APAC IBS-C Drug Sales by Type
6.3 APAC IBS-C Drug Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IBS-C Drug by Country
7.1.1 Europe IBS-C Drug Sales by Country (2019-2024)
7.1.2 Europe IBS-C Drug Revenue by Country (2019-2024)
7.2 Europe IBS-C Drug Sales by Type
7.3 Europe IBS-C Drug Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IBS-C Drug by Country
8.1.1 Middle East & Africa IBS-C Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa IBS-C Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa IBS-C Drug Sales by Type
8.3 Middle East & Africa IBS-C Drug Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IBS-C Drug
10.3 Manufacturing Process Analysis of IBS-C Drug
10.4 Industry Chain Structure of IBS-C Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IBS-C Drug Distributors
11.3 IBS-C Drug Customer
12 WORLD FORECAST REVIEW FOR IBS-C DRUG BY GEOGRAPHIC REGION
12.1 Global IBS-C Drug Market Size Forecast by Region
12.1.1 Global IBS-C Drug Forecast by Region (2025-2030)
12.1.2 Global IBS-C Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global IBS-C Drug Forecast by Type
12.7 Global IBS-C Drug Forecast by Distribution Channel
13 KEY PLAYERS ANALYSIS
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan IBS-C Drug Product Portfolios and Specifications
13.1.3 Allergan IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda IBS-C Drug Product Portfolios and Specifications
13.2.3 Takeda IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Sucampo Pharmaceuticals
13.3.1 Sucampo Pharmaceuticals Company Information
13.3.2 Sucampo Pharmaceuticals IBS-C Drug Product Portfolios and Specifications
13.3.3 Sucampo Pharmaceuticals IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sucampo Pharmaceuticals Main Business Overview
13.3.5 Sucampo Pharmaceuticals Latest Developments
13.4 IM HealthScience
13.4.1 IM HealthScience Company Information
13.4.2 IM HealthScience IBS-C Drug Product Portfolios and Specifications
13.4.3 IM HealthScience IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 IM HealthScience Main Business Overview
13.4.5 IM HealthScience Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IBS-C Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for IBS-C Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for IBS-C Drug by Country/Region, 2019, 2023 & 2030
2.2 IBS-C Drug Segment by Type
2.2.1 Amitiza
2.2.2 Lactulose
2.2.3 Milk of Magnesia
2.2.4 LINZESS (Linaclotide)
2.2.5 Others
2.3 IBS-C Drug Sales by Type
2.3.1 Global IBS-C Drug Sales Market Share by Type (2019-2024)
2.3.2 Global IBS-C Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global IBS-C Drug Sale Price by Type (2019-2024)
2.4 IBS-C Drug Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 IBS-C Drug Sales by Distribution Channel
2.5.1 Global IBS-C Drug Sale Market Share by Distribution Channel (2019-2024)
2.5.2 Global IBS-C Drug Revenue and Market Share by Distribution Channel (2019-2024)
2.5.3 Global IBS-C Drug Sale Price by Distribution Channel (2019-2024)
3 GLOBAL IBS-C DRUG BY COMPANY
3.1 Global IBS-C Drug Breakdown Data by Company
3.1.1 Global IBS-C Drug Annual Sales by Company (2019-2024)
3.1.2 Global IBS-C Drug Sales Market Share by Company (2019-2024)
3.2 Global IBS-C Drug Annual Revenue by Company (2019-2024)
3.2.1 Global IBS-C Drug Revenue by Company (2019-2024)
3.2.2 Global IBS-C Drug Revenue Market Share by Company (2019-2024)
3.3 Global IBS-C Drug Sale Price by Company
3.4 Key Manufacturers IBS-C Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IBS-C Drug Product Location Distribution
3.4.2 Players IBS-C Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IBS-C DRUG BY GEOGRAPHIC REGION
4.1 World Historic IBS-C Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global IBS-C Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global IBS-C Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic IBS-C Drug Market Size by Country/Region (2019-2024)
4.2.1 Global IBS-C Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global IBS-C Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas IBS-C Drug Sales Growth
4.4 APAC IBS-C Drug Sales Growth
4.5 Europe IBS-C Drug Sales Growth
4.6 Middle East & Africa IBS-C Drug Sales Growth
5 AMERICAS
5.1 Americas IBS-C Drug Sales by Country
5.1.1 Americas IBS-C Drug Sales by Country (2019-2024)
5.1.2 Americas IBS-C Drug Revenue by Country (2019-2024)
5.2 Americas IBS-C Drug Sales by Type
5.3 Americas IBS-C Drug Sales by Distribution Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IBS-C Drug Sales by Region
6.1.1 APAC IBS-C Drug Sales by Region (2019-2024)
6.1.2 APAC IBS-C Drug Revenue by Region (2019-2024)
6.2 APAC IBS-C Drug Sales by Type
6.3 APAC IBS-C Drug Sales by Distribution Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IBS-C Drug by Country
7.1.1 Europe IBS-C Drug Sales by Country (2019-2024)
7.1.2 Europe IBS-C Drug Revenue by Country (2019-2024)
7.2 Europe IBS-C Drug Sales by Type
7.3 Europe IBS-C Drug Sales by Distribution Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IBS-C Drug by Country
8.1.1 Middle East & Africa IBS-C Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa IBS-C Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa IBS-C Drug Sales by Type
8.3 Middle East & Africa IBS-C Drug Sales by Distribution Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IBS-C Drug
10.3 Manufacturing Process Analysis of IBS-C Drug
10.4 Industry Chain Structure of IBS-C Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IBS-C Drug Distributors
11.3 IBS-C Drug Customer
12 WORLD FORECAST REVIEW FOR IBS-C DRUG BY GEOGRAPHIC REGION
12.1 Global IBS-C Drug Market Size Forecast by Region
12.1.1 Global IBS-C Drug Forecast by Region (2025-2030)
12.1.2 Global IBS-C Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global IBS-C Drug Forecast by Type
12.7 Global IBS-C Drug Forecast by Distribution Channel
13 KEY PLAYERS ANALYSIS
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan IBS-C Drug Product Portfolios and Specifications
13.1.3 Allergan IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda IBS-C Drug Product Portfolios and Specifications
13.2.3 Takeda IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Sucampo Pharmaceuticals
13.3.1 Sucampo Pharmaceuticals Company Information
13.3.2 Sucampo Pharmaceuticals IBS-C Drug Product Portfolios and Specifications
13.3.3 Sucampo Pharmaceuticals IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sucampo Pharmaceuticals Main Business Overview
13.3.5 Sucampo Pharmaceuticals Latest Developments
13.4 IM HealthScience
13.4.1 IM HealthScience Company Information
13.4.2 IM HealthScience IBS-C Drug Product Portfolios and Specifications
13.4.3 IM HealthScience IBS-C Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 IM HealthScience Main Business Overview
13.4.5 IM HealthScience Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IBS-C Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. IBS-C Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Amitiza
Table 4. Major Players of Lactulose
Table 5. Major Players of Milk of Magnesia
Table 6. Major Players of LINZESS (Linaclotide)
Table 7. Major Players of Others
Table 8. Global IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global IBS-C Drug Sales Market Share by Type (2019-2024)
Table 10. Global IBS-C Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global IBS-C Drug Revenue Market Share by Type (2019-2024)
Table 12. Global IBS-C Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 14. Global IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Table 15. Global IBS-C Drug Revenue by Distribution Channel (2019-2024)
Table 16. Global IBS-C Drug Revenue Market Share by Distribution Channel (2019-2024)
Table 17. Global IBS-C Drug Sale Price by Distribution Channel (2019-2024) & (USD/Unit)
Table 18. Global IBS-C Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global IBS-C Drug Sales Market Share by Company (2019-2024)
Table 20. Global IBS-C Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global IBS-C Drug Revenue Market Share by Company (2019-2024)
Table 22. Global IBS-C Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers IBS-C Drug Producing Area Distribution and Sales Area
Table 24. Players IBS-C Drug Products Offered
Table 25. IBS-C Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global IBS-C Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global IBS-C Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global IBS-C Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global IBS-C Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global IBS-C Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global IBS-C Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global IBS-C Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global IBS-C Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas IBS-C Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas IBS-C Drug Sales Market Share by Country (2019-2024)
Table 38. Americas IBS-C Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas IBS-C Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 42. APAC IBS-C Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC IBS-C Drug Sales Market Share by Region (2019-2024)
Table 44. APAC IBS-C Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC IBS-C Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 48. Europe IBS-C Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe IBS-C Drug Sales Market Share by Country (2019-2024)
Table 50. Europe IBS-C Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe IBS-C Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 54. Middle East & Africa IBS-C Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa IBS-C Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa IBS-C Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa IBS-C Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of IBS-C Drug
Table 61. Key Market Challenges & Risks of IBS-C Drug
Table 62. Key Industry Trends of IBS-C Drug
Table 63. IBS-C Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. IBS-C Drug Distributors List
Table 66. IBS-C Drug Customer List
Table 67. Global IBS-C Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global IBS-C Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas IBS-C Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas IBS-C Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC IBS-C Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC IBS-C Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe IBS-C Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe IBS-C Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa IBS-C Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa IBS-C Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global IBS-C Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global IBS-C Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global IBS-C Drug Sales Forecast by Distribution Channel (2025-2030) & (K Units)
Table 80. Global IBS-C Drug Revenue Forecast by Distribution Channel (2025-2030) & ($ Millions)
Table 81. Allergan Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Allergan IBS-C Drug Product Portfolios and Specifications
Table 83. Allergan IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Allergan Main Business
Table 85. Allergan Latest Developments
Table 86. Takeda Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Takeda IBS-C Drug Product Portfolios and Specifications
Table 88. Takeda IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Takeda Main Business
Table 90. Takeda Latest Developments
Table 91. Sucampo Pharmaceuticals Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Sucampo Pharmaceuticals IBS-C Drug Product Portfolios and Specifications
Table 93. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sucampo Pharmaceuticals Main Business
Table 95. Sucampo Pharmaceuticals Latest Developments
Table 96. IM HealthScience Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. IM HealthScience IBS-C Drug Product Portfolios and Specifications
Table 98. IM HealthScience IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. IM HealthScience Main Business
Table 100. IM HealthScience Latest Developments
Table 1. IBS-C Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. IBS-C Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Amitiza
Table 4. Major Players of Lactulose
Table 5. Major Players of Milk of Magnesia
Table 6. Major Players of LINZESS (Linaclotide)
Table 7. Major Players of Others
Table 8. Global IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global IBS-C Drug Sales Market Share by Type (2019-2024)
Table 10. Global IBS-C Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global IBS-C Drug Revenue Market Share by Type (2019-2024)
Table 12. Global IBS-C Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 14. Global IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Table 15. Global IBS-C Drug Revenue by Distribution Channel (2019-2024)
Table 16. Global IBS-C Drug Revenue Market Share by Distribution Channel (2019-2024)
Table 17. Global IBS-C Drug Sale Price by Distribution Channel (2019-2024) & (USD/Unit)
Table 18. Global IBS-C Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global IBS-C Drug Sales Market Share by Company (2019-2024)
Table 20. Global IBS-C Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global IBS-C Drug Revenue Market Share by Company (2019-2024)
Table 22. Global IBS-C Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers IBS-C Drug Producing Area Distribution and Sales Area
Table 24. Players IBS-C Drug Products Offered
Table 25. IBS-C Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global IBS-C Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global IBS-C Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global IBS-C Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global IBS-C Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global IBS-C Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global IBS-C Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global IBS-C Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global IBS-C Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas IBS-C Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas IBS-C Drug Sales Market Share by Country (2019-2024)
Table 38. Americas IBS-C Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas IBS-C Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 42. APAC IBS-C Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC IBS-C Drug Sales Market Share by Region (2019-2024)
Table 44. APAC IBS-C Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC IBS-C Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 48. Europe IBS-C Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe IBS-C Drug Sales Market Share by Country (2019-2024)
Table 50. Europe IBS-C Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe IBS-C Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 54. Middle East & Africa IBS-C Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa IBS-C Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa IBS-C Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa IBS-C Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa IBS-C Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa IBS-C Drug Sales by Distribution Channel (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of IBS-C Drug
Table 61. Key Market Challenges & Risks of IBS-C Drug
Table 62. Key Industry Trends of IBS-C Drug
Table 63. IBS-C Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. IBS-C Drug Distributors List
Table 66. IBS-C Drug Customer List
Table 67. Global IBS-C Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global IBS-C Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas IBS-C Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas IBS-C Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC IBS-C Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC IBS-C Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe IBS-C Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe IBS-C Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa IBS-C Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa IBS-C Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global IBS-C Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global IBS-C Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global IBS-C Drug Sales Forecast by Distribution Channel (2025-2030) & (K Units)
Table 80. Global IBS-C Drug Revenue Forecast by Distribution Channel (2025-2030) & ($ Millions)
Table 81. Allergan Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Allergan IBS-C Drug Product Portfolios and Specifications
Table 83. Allergan IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Allergan Main Business
Table 85. Allergan Latest Developments
Table 86. Takeda Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Takeda IBS-C Drug Product Portfolios and Specifications
Table 88. Takeda IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Takeda Main Business
Table 90. Takeda Latest Developments
Table 91. Sucampo Pharmaceuticals Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Sucampo Pharmaceuticals IBS-C Drug Product Portfolios and Specifications
Table 93. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Sucampo Pharmaceuticals Main Business
Table 95. Sucampo Pharmaceuticals Latest Developments
Table 96. IM HealthScience Basic Information, IBS-C Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. IM HealthScience IBS-C Drug Product Portfolios and Specifications
Table 98. IM HealthScience IBS-C Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. IM HealthScience Main Business
Table 100. IM HealthScience Latest Developments
LIST OF FIGURES
Figure 1. Picture of IBS-C Drug
Figure 2. IBS-C Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IBS-C Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global IBS-C Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. IBS-C Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Amitiza
Figure 10. Product Picture of Lactulose
Figure 11. Product Picture of Milk of Magnesia
Figure 12. Product Picture of LINZESS (Linaclotide)
Figure 13. Product Picture of Others
Figure 14. Global IBS-C Drug Sales Market Share by Type in 2023
Figure 15. Global IBS-C Drug Revenue Market Share by Type (2019-2024)
Figure 16. IBS-C Drug Consumed in Hospital Pharmacies
Figure 17. Global IBS-C Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. IBS-C Drug Consumed in Retail Pharmacies
Figure 19. Global IBS-C Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 20. IBS-C Drug Consumed in Online Pharmacies
Figure 21. Global IBS-C Drug Market: Online Pharmacies (2019-2024) & (K Units)
Figure 22. Global IBS-C Drug Sales Market Share by Distribution Channel (2023)
Figure 23. Global IBS-C Drug Revenue Market Share by Distribution Channel in 2023
Figure 24. IBS-C Drug Sales Market by Company in 2023 (K Units)
Figure 25. Global IBS-C Drug Sales Market Share by Company in 2023
Figure 26. IBS-C Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global IBS-C Drug Revenue Market Share by Company in 2023
Figure 28. Global IBS-C Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global IBS-C Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas IBS-C Drug Sales 2019-2024 (K Units)
Figure 31. Americas IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC IBS-C Drug Sales 2019-2024 (K Units)
Figure 33. APAC IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe IBS-C Drug Sales 2019-2024 (K Units)
Figure 35. Europe IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa IBS-C Drug Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas IBS-C Drug Sales Market Share by Country in 2023
Figure 39. Americas IBS-C Drug Revenue Market Share by Country in 2023
Figure 40. Americas IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 42. United States IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC IBS-C Drug Sales Market Share by Region in 2023
Figure 47. APAC IBS-C Drug Revenue Market Share by Regions in 2023
Figure 48. APAC IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 50. China IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe IBS-C Drug Sales Market Share by Country in 2023
Figure 58. Europe IBS-C Drug Revenue Market Share by Country in 2023
Figure 59. Europe IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 61. Germany IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa IBS-C Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa IBS-C Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 70. Egypt IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of IBS-C Drug in 2023
Figure 76. Manufacturing Process Analysis of IBS-C Drug
Figure 77. Industry Chain Structure of IBS-C Drug
Figure 78. Channels of Distribution
Figure 79. Global IBS-C Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global IBS-C Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global IBS-C Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global IBS-C Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global IBS-C Drug Sales Market Share Forecast by Distribution Channel (2025-2030)
Figure 84. Global IBS-C Drug Revenue Market Share Forecast by Distribution Channel (2025-2030)
Figure 1. Picture of IBS-C Drug
Figure 2. IBS-C Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IBS-C Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global IBS-C Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. IBS-C Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Amitiza
Figure 10. Product Picture of Lactulose
Figure 11. Product Picture of Milk of Magnesia
Figure 12. Product Picture of LINZESS (Linaclotide)
Figure 13. Product Picture of Others
Figure 14. Global IBS-C Drug Sales Market Share by Type in 2023
Figure 15. Global IBS-C Drug Revenue Market Share by Type (2019-2024)
Figure 16. IBS-C Drug Consumed in Hospital Pharmacies
Figure 17. Global IBS-C Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 18. IBS-C Drug Consumed in Retail Pharmacies
Figure 19. Global IBS-C Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 20. IBS-C Drug Consumed in Online Pharmacies
Figure 21. Global IBS-C Drug Market: Online Pharmacies (2019-2024) & (K Units)
Figure 22. Global IBS-C Drug Sales Market Share by Distribution Channel (2023)
Figure 23. Global IBS-C Drug Revenue Market Share by Distribution Channel in 2023
Figure 24. IBS-C Drug Sales Market by Company in 2023 (K Units)
Figure 25. Global IBS-C Drug Sales Market Share by Company in 2023
Figure 26. IBS-C Drug Revenue Market by Company in 2023 ($ Million)
Figure 27. Global IBS-C Drug Revenue Market Share by Company in 2023
Figure 28. Global IBS-C Drug Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global IBS-C Drug Revenue Market Share by Geographic Region in 2023
Figure 30. Americas IBS-C Drug Sales 2019-2024 (K Units)
Figure 31. Americas IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 32. APAC IBS-C Drug Sales 2019-2024 (K Units)
Figure 33. APAC IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 34. Europe IBS-C Drug Sales 2019-2024 (K Units)
Figure 35. Europe IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa IBS-C Drug Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa IBS-C Drug Revenue 2019-2024 ($ Millions)
Figure 38. Americas IBS-C Drug Sales Market Share by Country in 2023
Figure 39. Americas IBS-C Drug Revenue Market Share by Country in 2023
Figure 40. Americas IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 41. Americas IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 42. United States IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC IBS-C Drug Sales Market Share by Region in 2023
Figure 47. APAC IBS-C Drug Revenue Market Share by Regions in 2023
Figure 48. APAC IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 49. APAC IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 50. China IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. India IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe IBS-C Drug Sales Market Share by Country in 2023
Figure 58. Europe IBS-C Drug Revenue Market Share by Country in 2023
Figure 59. Europe IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 60. Europe IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 61. Germany IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. France IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa IBS-C Drug Sales Market Share by Country in 2023
Figure 67. Middle East & Africa IBS-C Drug Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa IBS-C Drug Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa IBS-C Drug Sales Market Share by Distribution Channel (2019-2024)
Figure 70. Egypt IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country IBS-C Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of IBS-C Drug in 2023
Figure 76. Manufacturing Process Analysis of IBS-C Drug
Figure 77. Industry Chain Structure of IBS-C Drug
Figure 78. Channels of Distribution
Figure 79. Global IBS-C Drug Sales Market Forecast by Region (2025-2030)
Figure 80. Global IBS-C Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global IBS-C Drug Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global IBS-C Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global IBS-C Drug Sales Market Share Forecast by Distribution Channel (2025-2030)
Figure 84. Global IBS-C Drug Revenue Market Share Forecast by Distribution Channel (2025-2030)
